Search for content, post, videos

STADA and Xbrane launch ranibizumab in Europe

Martin Åmark
Ranibizumab biosimilar is being launched in major European markets. Ranibizumab is the first product brought to market through a strategic collaboration between STADA and Xbrane Biopharma, marking Xbrane’s first commercial launch and STADA’s first co-development asset, in its growing biosimil
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.